Bruker (BRKR) Other Accumulated Expenses (2010 - 2026)

Bruker (BRKR) has reported Other Accumulated Expenses for 17 consecutive years, with $549.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses fell 3.65% year-over-year to $549.8 million; the trailing twelve-month figure through Jun 2026 stood at $549.8 million (down 3.65% YoY), and the FY2025 full-year result was $605.4 million, up 5.01% from the prior year.
• Other Accumulated Expenses declined to $549.8 million in Q2 2026 per BRKR's latest filing, from $597.9 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $605.4 million in Q4 2025 and bottomed at $334.4 million in Q1 2023.
• Historically, Other Accumulated Expenses has averaged $504.3 million across 5 years, with a median of $532.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses tumbled 32.25% in 2023, then jumped 61.69% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $347.0 million in 2022, then surged by 37.81% to $478.2 million in 2023, then rose by 20.56% to $576.5 million in 2024, then gained by 5.01% to $605.4 million in 2025, then dropped by 9.18% to $549.8 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $549.8 million, $597.9 million, and $605.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.